文献速递慢性静脉疾病

不全性大隐静脉合并节段性腘静脉反流治疗后的临床结局

Clinical outcomes after treatment of incompetent saphenous vein combined with segmental popliteal vein reflux.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2024-05-27

本研究纳入2016年7月至2021年7月接受不全性大隐静脉治疗的患者233例(398条肢体),分为无深静脉反流组与节段性腘静脉反流组,比较术后生活质量变化与并发症率。结果显示两组并发症率无显著差异(1.8% vs 1.6%,P=.896),术后6及12个月静脉临床严重程度评分与Aberdeen静脉曲张问卷评分均改善但组间无显著差异,节段性腘静脉反流改善率为25%(16/64)。

要点

  • 节段性腘静脉反流患者不全性大隐静脉治疗后并发症率与无深静脉反流者无显著差异(1.8% vs 1.6%,P=.896)。
  • 两组术后6及12个月静脉临床严重程度评分与Aberdeen静脉曲张问卷评分均改善,但组间无显著差异。
  • 节段性腘静脉反流改善率为25%(16/64),患者报告结局改善与治疗方式、大隐静脉治疗节段及术后反流改善无关。

核心结论

  • 不全性大隐静脉治疗后,存在节段性腘静脉反流者的并发症率与临床结局与无深静脉反流者无差异。
  • 节段性腘静脉反流患者不全性大隐静脉治疗后生活质量改善,与治疗方式、大隐静脉治疗节段及术后节段性腘静脉反流改善无关。

研究设计与样本

  • 纳入2016年7月至2021年7月接受不全性大隐静脉治疗的患者,分为无深静脉反流组与节段性腘静脉反流组。
  • 排除轴向深静脉反流、深静脉血栓史、骨科手术史、既往静脉治疗及无术后随访者,术前及术后6、12个月行双功超声检查。
  • 共纳入233例患者(398条肢体),其中50例(64条肢体)存在节段性腘静脉反流。

主要发现

  • 两组在性别、年龄、体重指数、临床-病因-解剖-病理生理分类分布、侧别、治疗方式及术前静脉临床严重程度评分或Aberdeen静脉曲张问卷评分方面无差异。
  • 术后6及12个月静脉临床严重程度评分与Aberdeen静脉曲张问卷评分在两组均改善,但组间无显著差异。
  • 术后并发症率在节段性腘静脉反流组为1.8%,无深静脉反流组为1.6%,组间无显著差异(P=.896)。
  • 不全性大隐静脉治疗后节段性腘静脉反流改善率为25%(16/64)。
  • 合并节段性腘静脉反流者的患者报告结局改善与治疗方式、大隐静脉治疗节段及术后节段性腘静脉反流改善无关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to evaluate whether differences exist in the quality of life changes and complication rates after treatment of incompetent saphenous vein (ISV) based on the presence of segmental popliteal vein reflux (SPVR). METHODS: Patients who underwent treatment for ISV from July 2016 to July 2021 were included and divided into two groups: patients without deep venous reflux (DVR) and patients with SPVR. Patients with axial DVR, a history of deep vein thrombosis, a history of orthopedic surgery, previous venous treatment, and no postoperative follow-up were excluded from the study. Duplex ultrasound examination was performed preoperatively and at 6 and 12 months postoperatively. RESULTS: The study included 233 patients (398 limbs), and 50 (64 limbs) had SPVR. Differences were not observed in gender, age, body mass index, distribution of clinical class according to Clinical-Etiology-Anatomy-Physiology classification, laterality, treatment method, and preoperative Venous Clinical Severity Score or Aberdeen Varicose Vein Questionnaire scores between the two groups with SPVR or without DVR. Furthermore, the Venous Clinical Severity Score and Aberdeen Varicose Vein Questionnaire scores at 6 and 12 months postoperatively were improved in both groups, although without significant differences. A significant difference was not observed in the rate of postoperative complications between the groups based on the presence of SPVR (1.8% vs 1.6%: P = .896). The SPVR improvement rate after ISV treatment was 25% (16/64), and patient-reported outcomes in patients combined with SPVR improved independent of treatment modality, saphenous vein treatment section, and postoperative SPVR improvement. CONCLUSIONS: Complication rates and clinical outcomes after ISV treatment did not differ in the presence of SPVR. In patients with SPVR, after ISV treatment, quality of life improved regardless of treatment modality, saphenous vein treatment section, and postoperative SPVR improvement.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Hong KP. Clinical outcomes after treatment of incompetent saphenous vein combined with segmental popliteal vein reflux. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 38810693. doi:10.1016/j.jvsv.2024.101918

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。